Clonal evolution of 8p11 stem cell syndrome in a 14-year-old Chinese boy: A review of literature of t(8;13) associated myeloproliferative diseases

Leukemia Research

Volumn 31, Issue 2, 2007, Pages 235-238

  Wong, Wai Shan ^a   Cheng, Kelvin Chi Keung ^a   Lau, Kin Mang ^a   Chan, Natalie Pui Ha ^a   Shing, Matthew Ming Kong ^a   Cheng, Suk Hang ^a   Chik, Ki Wai ^a   Li, Chi Kong ^a   Ng, Margaret Heung Ling ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

8p11 stem cell syndrome; FGFR1; Myeloproliferative disease; Precursor T cell lymphoblastic lymphoma

Indexed keywords

BCR ABL PROTEIN; FIBROBLAST GROWTH FACTOR RECEPTOR 1;

8P11 STEM CELL SYNDROME; ABDOMINAL MASS; ADOLESCENT; ARTICLE; BONE MARROW; CASE REPORT; CHINESE; CHROMOSOME 8P; CLINICAL FEATURE; CLONE; GENE FUSION; GENE MUTATION; GENE REARRANGEMENT; GENETIC DISORDER; HUMAN; HUMAN TISSUE; LYMPH NODE; LYMPHADENOPATHY; MALE; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T CELL LYMPHOMA;

ADOLESCENT; BONE MARROW; CELL TRANSFORMATION, NEOPLASTIC; CHINA; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 8; CLONE CELLS; DISEASE PROGRESSION; GENES, T-CELL RECEPTOR GAMMA; HEMATOPOIETIC STEM CELLS; HUMANS; LYMPHOMA, LYMPHOBLASTIC; MALE; MYELOPROLIFERATIVE DISORDERS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; REMISSION INDUCTION; SYNDROME; TRANSLOCATION, GENETIC;

EID: 33845225471     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2006.04.015     Document Type: Article

References (19)

1. Macdonald D., Reiter A., and Cross N.C. The 8p11 myeloproliferative syndrome: a distinct clinical entity caused by constitutive activation of FGFR1. Acta Haematologica 107 (2002) 101-107
2. JabbarAl-Obaidi M.J., Rymes N., White P., Pomfret M., Smith H., Starczynski J., et al. A fourth case of 8p11 myeloproliferative disorder transformation to B-lineage acute lymphoblastic leukaemia. Acta Haematol 107 (2002) 98-100
3. Roy S., Szer J., Campbell L.J., and Juneja S. Sequential transformation of t(8;13)-related disease: a case report. Acta Hamatol 107 (2002) 95-97
4. Albitar M., and Freireich E.J. Molecular defects in chronic myeloproliferative disorders. Mol Med 6 7 (2000) 555-567
5. Popovici C., Adélaïde J., Ollendorff V., Chaffanet M., Guasch G., Jacrot M., et al. Fibroblast growth factor receptor 1 is fused to FIM in stem-cell myeloproliferative disorder with t(8;13)(p12;q12). Proc Natl Acad Sci 95 (1998) 5712-5717
6. van Dongen J.J., Langerak A.W., Bruggemann M., Evans P.A., Hummel M., Lavender F.L., et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 17 12 (2003) 2257-2317
7. Still I.H., and Cowell J.K. The t(8;13) atypical myeloproliferative disorder: further analysis of the ZNF198 gene and lack of evidence for multiple genes disrupted on chromosome 13. Blood 92 (1998) 1456-1458
8. Abruzzo L.V., Jaffe E.S., Cotelingam J.D., Whang-Peng J., Del Duca V., and Medeiros L.J. T-cell lymphoblastic lymphoma with eosinophilia associated with subsequent myeloid malignancy. Am J Surg Pathol 16 (1992) 236-245
9. Rao P.H., Cesarman G., Coleman M., Acaron S., and Verma R.S. Cytogenetic evidence for extramedullary crisis with t(8;13)(p11;q11) in chronic myelomonocytic leukaemia. Acta Haematol 88 (1992) 201-203
10. Fagan K., Hyde S., Harrison P., and Translocation. (8;13) and T-cell lymphoma: a case report. Cancer Genet Cytogenet 65 (1993) 71-73
11. Leslie J., Barker T., Glancy M., Jennings B., and Pearson J. t(8;13)(p11;q12) translocation in a myeloproliferative disorder associated with a T-cell non-Hodgkin lymphoma. Brit J Haematol 86 (1994) 876-878
12. Macdonald D., Sherrin S.M., Cross N.C.P., Spencer A., and Goldman J.M. An atypical myeloproliferative disorder with t(8;13)(p11;q12): a third case. Brit J Haematol 86 (1994) 879-880
13. Inhorn R.C., Aster J.C., Roach S.A., Slapak C.A., Soiffer R., Tantravahi R., et al. A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia/malignancy associated with t(8;13)(p11;q11): description of a distinctive clinicopathologic entity. Blood 85 (1995) 1881-1887
14. Michaux L., Mecucci C., Pereira R., Vellosa E., Dierlamm J., Criel A., et al. About the t(8;13)(p11;q12) clinico-pathologic entity. Blood 87 (1996) 1658-1659
15. Martinez-Climent J.A., Vizcarra E., Benet I., Marugan I., Terol M.J., Solano C., et al. Cytogenetic response induced by interferon-alpha in the myeloproliferative disorder with eosinophilia, T-cell lymphoma and the chromosomal translocation t(8;13)(p11;q12). Leukaemia 12 (1998) 999-1000
16. Chernova O., Still I., Kalaycio M., Hoeltge G., and Cowell J.K. Characterization of the breakpoints in a t(8;13)(p11;q12) translocation from a patient with myeloproliferative disease using florescence in situ hybridization. Genes, Chrom Cancer 21 (1998) 160-165
17. Suzan F., Guasch G., Terre C., Garcia I., Bastie J.N., Maarek O., et al. Long-term complete haematological and molecular remission after allogeneic bone marrow transplantation in a patient with a stem cell myeloproliferative disorder associated with t(8;13)(p12;q12). Brit. J. Haematol. 121 (2003) 312-314
18. Invernizzi R., Benatti C., Travaglino E., Girino M., Bernasconi P., Loni C., et al. A further case of myeloproliferative syndrome with reciprocal translocation (8;13)(p11;q12). Haematologica 89 (2004) 239-241
19. Chen J., Deangelo D.J., Kutok J.L., et al. PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder. Proc Natl Acad Sci 101 (2004) 14479-14484